Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to David L. Wyles

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Wyles, David

One or more keywords matched the following items that are connected to Wyles, David

Item Type	Name
Concept	Hepatitis B virus
Academic Article	Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial.
Academic Article	Hepatitis C virus drug resistance: implications for clinical management.
Academic Article	High incidence of serious adverse events in HIV-infected patients treated with a telaprevir-based hepatitis C virus treatment regimen.
Academic Article	TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir.
Academic Article	Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study.
Academic Article	Interferon ?-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune response.
Academic Article	Grazoprevir, ruzasvir, and uprifosbuvir for hepatitis C virus after NS5A treatment failure.
Academic Article	Antiviral resistance and the future landscape of hepatitis C virus infection therapy.
Academic Article	Antiviral drug advances in the treatment of human immunodeficiency virus (HIV) and chronic hepatitis C virus (HCV).
Academic Article	Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials.
Academic Article	Understanding Hepatitis C Virus Drug Resistance: Clinical Implications for Current and Future Regimens.
Academic Article	Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals.
Academic Article	Vitamin D Metabolites Inhibit Hepatitis C Virus and Modulate Cellular Gene Expression.
Academic Article	Conformational inhibition of the hepatitis C virus internal ribosome entry site RNA.
Academic Article	Beyond telaprevir and boceprevir: resistance and new agents for hepatitis C virus infection.
Academic Article	Structure of a hepatitis C virus RNA domain in complex with a translation inhibitor reveals a binding mode reminiscent of riboswitches.
Academic Article	Synthesis and antiviral evaluation of 9-(S)-[3-alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replication.
Academic Article	Emerging complexities with hepatitis C virus direct-acting antiviral regimens: Less is still Way more.
Academic Article	Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study.
Academic Article	Early identification and linkage to care of persons with chronic hepatitis B virus infection--three U.S. sites, 2012-2014.
Academic Article	Moving beyond interferon alfa: investigational drugs for hepatitis C virus infection.
Academic Article	3-drug synergistic interactions of small molecular inhibitors of hepatitis C virus replication.
Academic Article	Update on hepatitis C virus resistance to direct-acting antiviral agents.
Academic Article	Synergy of small molecular inhibitors of hepatitis C virus replication directed at multiple viral targets.
Academic Article	Post-treatment resistance analysis of hepatitis C virus from phase II and III clinical trials of ledipasvir/sofosbuvir.
Academic Article	Synergy of a hepatitis C virus (HCV) NS4A antagonist in combination with HCV protease and polymerase inhibitors.
Academic Article	The octadecyloxyethyl ester of (S)-9-[3-hydroxy-2-(phosphonomethoxy) propyl]adenine is a potent and selective inhibitor of hepatitis C virus replication in genotype 1A, 1B, and 2A replicons.
Academic Article	Alkoxyalkyl esters of 9-(s)-(3-hydroxy-2-phosphonomethoxypropyl) adenine are potent and selective inhibitors of hepatitis B virus (HBV) replication in vitro and in HBV transgenic mice in vivo.
Academic Article	Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial.
Academic Article	Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ? Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2.
Academic Article	Ledipasvir-sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimens.
Academic Article	A modular approach to synthetic RNA binders of the hepatitis C virus internal ribosome entry site.
Academic Article	Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials.
Academic Article	Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.
Grant	Analysis of HIV/HCV Sexual Transmission Pairs Using Ultra-Deep Sequencing
Grant	An in vitro system to study antiviral strategies against Hepatitis C virus
Academic Article	Antiretroviral Effects on HBV/HIV Co-infection and the Natural History of Liver Disease.
Academic Article	Primary Incidence of Hepatitis C Virus Infection Among HIV-Infected Men Who Have Sex With Men in San Diego, 2000-2015.
Academic Article	Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection.
Academic Article	Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepatitis C virus genotype 1 or 2 infection.
Academic Article	Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study.
Academic Article	Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials.
Academic Article	Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s.
Academic Article	Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation.
Academic Article	Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection: Fulfilling the Potential on the Road to Elimination.
Academic Article	Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).
Academic Article	A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial.
Academic Article	The use of technology-based adherence monitoring in the treatment of hepatitis C virus.

Search Criteria

Hepatitis B virus